2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow Head & Neck Squamous Cell Carcinoma: new trials by email Literature Review of Head & Neck Squamous Cell Carcinoma trials Research Report on Head & Neck Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma Bemcentinib, Nimotuzumab, radiotherapy - Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer | Phase 3 | Recruiting | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 370 | 2026-03-04 | 2026-04-17 |
| Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Nimotuzumab, intensity-modulated technique（IMRT） - Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer | Phase 3 | Recruiting | Shandong Cancer Hospital and Institute | 335 | 2026-01-05 | 2026-01-12 |
Head and Neck Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2)
Carcinoma (2) · Carcinoma, Squamous Cell (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2)
nimotuzumab (2) · Radiotherapy (1) · bemcentinib (1)
Shandong Cancer Hospital and Institute (1) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)
China (2)
Man Hu (1)